Socios de la ACNP Ingresar

Blog

Fibrosis quística

Palivizumab and Long-term Outcomes in Cystic Fibrosis

By gestor
4 septiembre, 2019
0 Comments
104 Views

Palivizumab and Long-term Outcomes in Cystic Fibrosis

Loader Loading...
EAD Logo Taking too long?
Reload Reload document
| Open Open in new tab

Related posts

Nov 10, 2019

Probióticos en fibrosis quística

Ago 25, 2019

Association of vitamin D status with lung function measurements in children and adolescents with cystic fibrosis

Jun 29, 2019

Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis

Write a Comment

Categorías

Suscríbase a nuestra Newletter

© 2022 Asociación Colombiana de Neumología Pediátrica

Hit enter to search or ESC to close